Search

everythinglearnresearchcommunity

for

Search:↓

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Early hair loss may indicate risk of insulin resistance.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study aims to understand various diseases in older adults.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Higher aldosterone levels link to hair loss and high blood pressure.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.